Laure Riffault
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Laure Riffault has a total of 40 co-authors. Here are the top co-authors by number of shared publications:
Annick Clement
3 shared publications- Loïc Guillot
Sorbonne Université, Inserm, Centre de Recherche Saint Antoine, Paris F-75012, France
2 shared publications - Mohammed Taouis
Molecular Neuroendocrinology of Food Intake (NMPA), CNRS UMR 9197, University of Paris-Saclay, Orsay, France
2 shared publications - Olivier Tabary
Sorbonne Université, INSERM, Centre de Recherche Saint-Antoine, CRSA, Paris, France
2 shared publications - Yacir Benomar
Paris-Saclay Institute of Neurosciences (NeuroPSI), University of Paris-Saclay, CNRS, F-91400 Saclay, France
2 shared publications Anne-Marie Durand-Schneider
Inserm U938 and
1 shared publication
Latest Publications
- 1 March 2014
- Published by Elsevier in Molecular and Cellular Endocrinology
- Vol. 384 (1-2) , 1-11
The over-expression of miR-200a in the hypothalamus of ob/ob mice is linked to leptin and insulin signaling impairment
- 1 March 2014
- Published by Elsevier in Molecular and Cellular Endocrinology
- Vol. 384 (1-2) , 1-11
The over-expression of miR-200a in the hypothalamus of ob/ob mice is linked to leptin and insulin signaling impairment
- Open Access
- 13 December 2012
- Published by American Diabetes Association in Diabetes
- Vol. 62 (1) , 102-114
Central Resistin Overexposure Induces Insulin Resistance Through Toll-Like Receptor 4
Resistin promotes both inflammation and insulin resistance associated with energy homeostasis impairment. However, the resistin receptor and the molecular mechanisms mediating its effects in the hypothalamus, crucial for energy homeostasis control, and key insulin-sensitive tissues are still unknown. In the current study, we report that chronic resistin infusion in the lateral cerebral ventricle of normal rats markedly affects both hypothalamic and peripheral insulin responsiveness. Central resistin treatment inhibited insulin-dependent phosphorylation of insulin receptor (IR), AKT, and extracellular signal–related kinase 1/2 associated with reduced IR expression and with upregulation of suppressor of cytokine signaling-3 and phosphotyrosine phosphatase 1B, two negative regulators of insulin signaling. Additionally, central resistin promotes the activation of the serine kinases Jun NH2-terminal kinase and p38 mitogen-activated protein kinase, enhances the serine phosphorylation of insulin receptor substrate-1, and increases the expression of the proinflammatory cytokine interleukin-6 in the hypothalamus and key peripheral insulin-sensitive tissues. Interestingly, we also report for the first time, to our knowledge, the direct binding of resistin to Toll-like receptor (TLR) 4 receptors in the hypothalamus, leading to the activation of the associated proinflammatory pathways. Taken together, our findings clearly identify TLR4 as the binding site for resistin in the hypothalamus and bring new insight into the molecular mechanisms involved in resistin-induced inflammation and insulin resistance in the whole animal.
- 13 December 2012
- Published by American Diabetes Association in Diabetes
- Vol. 62 (1) , 102-114
Open AccessCentral Resistin Overexposure Induces Insulin Resistance Through Toll-Like Receptor 4
Resistin promotes both inflammation and insulin resistance associated with energy homeostasis impairment. However, the resistin receptor and the molecular mechanisms mediating its effects in the hypothalamus, crucial for energy homeostasis control, and key insulin-sensitive tissues are still unknown. In the current study, we report that chronic resistin infusion in the lateral cerebral ventricle of normal rats markedly affects both hypothalamic and peripheral insulin responsiveness. Central resistin treatment inhibited insulin-dependent phosphorylation of insulin receptor (IR), AKT, and extracellular signal–related kinase 1/2 associated with reduced IR expression and with upregulation of suppressor of cytokine signaling-3 and phosphotyrosine phosphatase 1B, two negative regulators of insulin signaling. Additionally, central resistin promotes the activation of the serine kinases Jun NH2-terminal kinase and p38 mitogen-activated protein kinase, enhances the serine phosphorylation of insulin receptor substrate-1, and increases the expression of the proinflammatory cytokine interleukin-6 in the hypothalamus and key peripheral insulin-sensitive tissues. Interestingly, we also report for the first time, to our knowledge, the direct binding of resistin to Toll-like receptor (TLR) 4 receptors in the hypothalamus, leading to the activation of the associated proinflammatory pathways. Taken together, our findings clearly identify TLR4 as the binding site for resistin in the hypothalamus and bring new insight into the molecular mechanisms involved in resistin-induced inflammation and insulin resistance in the whole animal.
- 1 May 2012
- Published by Elsevier in Cellular Signalling
- Vol. 24 (5) , 1093-1099
Glucocorticoids reduce inflammation in cystic fibrosis bronchial epithelial cells
- 1 May 2012
- Published by Elsevier in Cellular Signalling
- Vol. 24 (5) , 1093-1099
Glucocorticoids reduce inflammation in cystic fibrosis bronchial epithelial cells
- 7 November 2011
- Published by Oxford University Press (OUP) in Human Molecular Genetics
- Vol. 21 (4) , 765-775
Molecular and cellular characteristics of ABCA3 mutations associated with diffuse parenchymal lung diseases in children
ABCA3 (ATP-binding cassette subfamily A, member 3) is expressed in the lamellar bodies of alveolar type II cells and is crucial to pulmonary surfactant storage and homeostasis. ABCA3 gene mutations have been associated with neonatal respiratory distress (NRD) and pediatric interstitial lung disease (ILD). The objective of this study was to look for ABCA3 gene mutations in patients with severe NRD and/or ILD. The 30 ABCA3 coding exons were screened in 47 patients with severe NRD and/or ILD. ABCA3 mutations were identified in 10 out of 47 patients, including 2 homozygous, 5 compound heterozygous and 3 heterozygous patients. SP-B and SP-C expression patterns varied across patients. Among patients with ABCA3 mutations, five died shortly after birth and five developed ILD (including one without NRD). Functional studies of p.D253H and p.T1173R mutations revealed that p.D253H and p.T1173R induced abnormal lamellar bodies. Additionally, p.T1173R increased IL-8 secretion in vitro. In conclusion, we identified new ABCA3 mutations in patients with life-threatening NRD and/or ILD. Two mutations associated with ILD acted via different pathophysiological mechanisms despite similar clinical phenotypes.
- 7 November 2011
- Published by Oxford University Press (OUP) in Human Molecular Genetics
- Vol. 21 (4) , 765-775
Molecular and cellular characteristics of ABCA3 mutations associated with diffuse parenchymal lung diseases in children
ABCA3 (ATP-binding cassette subfamily A, member 3) is expressed in the lamellar bodies of alveolar type II cells and is crucial to pulmonary surfactant storage and homeostasis. ABCA3 gene mutations have been associated with neonatal respiratory distress (NRD) and pediatric interstitial lung disease (ILD). The objective of this study was to look for ABCA3 gene mutations in patients with severe NRD and/or ILD. The 30 ABCA3 coding exons were screened in 47 patients with severe NRD and/or ILD. ABCA3 mutations were identified in 10 out of 47 patients, including 2 homozygous, 5 compound heterozygous and 3 heterozygous patients. SP-B and SP-C expression patterns varied across patients. Among patients with ABCA3 mutations, five died shortly after birth and five developed ILD (including one without NRD). Functional studies of p.D253H and p.T1173R mutations revealed that p.D253H and p.T1173R induced abnormal lamellar bodies. Additionally, p.T1173R increased IL-8 secretion in vitro. In conclusion, we identified new ABCA3 mutations in patients with life-threatening NRD and/or ILD. Two mutations associated with ILD acted via different pathophysiological mechanisms despite similar clinical phenotypes.
- 1 August 2011
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 411 (3) , 471-476
Reduced expression of Tis7/IFRD1 protein in murine and human cystic fibrosis airway epithelial cell models homozygous for the F508del-CFTR mutation
- 1 August 2011
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 411 (3) , 471-476
Reduced expression of Tis7/IFRD1 protein in murine and human cystic fibrosis airway epithelial cell models homozygous for the F508del-CFTR mutation